FierceBiotech and its family of publications provide end-to-end coverage of biotech and medtech, from pre-clinical science through clinical testing and regulatory approval—and all the seed funding, venture capital, licensing deals, IPOs and M&A that happen along the way. We track tiny, virtual startups and the biggest of Big Pharma, highlighting the accomplishments and acknowledging the defeats that all of them experience on their way to market with a new therapy or device. The FierceBiotech team transcends the daily as well, with comprehensive coverage of key medical meetings plus special reports that highlight up-and-comers and shed new light on industry heavyweights.
Every business day, FiercePharma updates pharmaceutical executives on company news and earnings, FDA regulations, drug safety, generic drug companies, and more. Beyond the news of the day, our editors produce in-depth features on industry leaders and market trends. As a member of our community, you will receive an exclusive invitation to each of our webinars and gain full access to our entire white paper and eBook library. Advance your career by attending our networking parties and taking full advantage of our job board. Visit our website and start receiving our free FiercePharma email newsletter!
American Pharmaceutical Review is the leading review journal for business and technology in the pharmaceutical industry throughout North America. Each issue offers American Pharmaceutical Review's 30,000 readers unbiased editorial coverage of the latest developments in: drug delivery, information technology, research & development, analytical development and control, equipment and facility manufacturing and regulatory affairs. With its in-depth coverage, American Pharmaceutical Review is able to keep its readership of senior executives, technical personnel, scientists, and others fully abreast of the latest trends and developments in the process of pharmaceutical manufacturing.
The founders of CanBiotech from institutions including M.I.T, Harvard, Brown, McGill, University of Waterloo and University of Toronto, aim to create a central hub for the bio-medical industry through its portals and marketplaces, with equal, yet distinct representation of each of the bio-medical sectors: therapeutics/biopharmaceuticals, agrifood, devices/diagnostics.
The founders of CanBiotech bring over 13 years of experience in molecular biology, cancer biology, gene therapy, drug delivery, bio-IT, biopharmaceutical business development, software and web development from various arenas including the biopharmaceutical industry, the agbiotech industry, the financial industry and the public sector.
CanBiotech, a private venture, is a company whose central premise is forming partnerships and creating synergies with a focus on the outsourcing of biomedical research and business services through CanBiotech's online marketplaces or through CanBiotech's physical arm: CanBiotech Consulting. The goal is to enhance the biomedical industry, enabling a new process of discovery and development, with an equal opportunity provided to all players, by fostering both cross-border interactivity between Canadian and U.S. biomedical companies as well as provide for international partnering opportunities for the biomedical industry.
MEDtube is an innovative video education platform for health professionals. It allows sharing videos and other materials with a community of more than 110,000 users worldwide, as well as building e-learning courses. The videoteque is updated daily and now contains almost 15,000 videos.
PharmaLeaders.com is an online environment dedicated to enriching the careers of more than 200,000 life sciences professionals. With breaking news and informative content grouped into one of nine segmented channels, in-depth special reports, job and events postings, and so much more, industry executives, manufacturers, marketers and educators can count on PharmaLeaders for the tools they need to succeed in today’s competitive market environment. For more information, visit us online at www.pharmaleaders.com, write to us at [email protected] or call 888-400-1573, ext. 240
STAT delivers fast, deep, and tough-minded journalism about life sciences and the fast-moving business of making medicines. We take you inside academic labs, biotech boardrooms, and political backrooms. We cast a critical eye on scientific discoveries, scrutinize corporate strategies, and chronicle roiling battles for talent, money, and market share. We examine controversies and puncture hype. With an award-winning newsroom, STAT gives you indispensable insights and exclusive stories on the technologies, personalities, power brokers, and political forces driving massive changes in the life science industry — and a revolution in human health. These are the stories that matter to us all.